These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8693919)

  • 1. A new, stable preservation method for cytologic specimens for immunocytochemical analysis.
    Okuyama T; Matsuo S; Osaka M; Takahashi R
    Acta Cytol; 1996; 40(4):853-4. PubMed ID: 8693919
    [No Abstract]   [Full Text] [Related]  

  • 2. Grading of upper urinary tract transitional cell carcinoma by computed DNA content and p53 expression.
    Minimo C; Tawfiek ER; Bagley DH; McCue PA; Bibbo M
    Urology; 1997 Dec; 50(6):869-74. PubMed ID: 9426716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Back to the drawing board on immunohistochemistry and predictive factors.
    Henson DE
    J Natl Cancer Inst; 2005 Dec; 97(24):1796-7. PubMed ID: 16368935
    [No Abstract]   [Full Text] [Related]  

  • 4. Contribution of immunocytochemistry in routine diagnostic cytology.
    Lai CR; Pan CC; Tsay SH
    Diagn Cytopathol; 1996 May; 14(3):221-5. PubMed ID: 8732651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?
    Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ
    Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of p53 protein in ameloblastoma types.
    el-Sissy NA
    East Mediterr Health J; 1999 May; 5(3):478-89. PubMed ID: 10793827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
    McCabe A; Dolled-Filhart M; Camp RL; Rimm DL
    J Natl Cancer Inst; 2005 Dec; 97(24):1808-15. PubMed ID: 16368942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of phosphatase and tensin homolog, beta-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparations.
    Norimatsu Y; Miyamoto M; Kobayashi TK; Moriya T; Shimizu K; Yanoh K; Tsukayama C; Miyake Y; Ohno E
    Cancer; 2008 Jun; 114(3):155-64. PubMed ID: 18431720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of heat-labile antigens on air-dried cytologic specimens for immunocytochemical analysis.
    Baba N; Kawabata H; Kanno T; Ueno T; Makuuchi M; Morishita Y; Mori S; Sasaki J; Soejima K
    Acta Cytol; 1998; 42(3):707-15. PubMed ID: 9622692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current aspects in histopathological assessment of breast cancer].
    Sastre X
    Bull Cancer; 1997 Jan; 84(1):65-8. PubMed ID: 9180862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the immunohistochemical detection of p53 protein in endoscopic biopsy specimens.
    Jiang H; Han P; Jiang Y; Liang X; Hu C; Yang D
    Chin Med J (Engl); 1997 Mar; 110(3):202-5. PubMed ID: 9594341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
    Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
    Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised learning-based cell image segmentation for p53 immunohistochemistry.
    Mao KZ; Zhao P; Tan PH
    IEEE Trans Biomed Eng; 2006 Jun; 53(6):1153-63. PubMed ID: 16761842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P53 protein in adenocarcinoma of the large intestine].
    Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of p53 in human tumors: immunocytochemistry.
    Slade N; Moll UM
    Methods Mol Biol; 2003; 234():231-43. PubMed ID: 12824536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hard liquor for preservative of sputum.
    Takeda M; Lang WR; Horstmann JP; Hseih EW
    Acta Cytol; 1977; 21(3):369-70. PubMed ID: 268115
    [No Abstract]   [Full Text] [Related]  

  • 19. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein expression in cutaneous squamous cell carcinoma.
    Auepemkiate S; Boonyaphiphat P; Sriplung H
    J Med Assoc Thai; 2000 May; 83(5):543-8. PubMed ID: 10863901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.